[Gestrinone in the therapy of sterility due to endometriosis].

Thirty-two infertile women with laparoscopic diagnosis of asymptomatic pelvic endometriosis were treated with gestrinone 2.5 mg twice weekly for 6 months. Subsequently, a second-look laparoscopy was performed in all of them. All of the patients were followed for at least 12 months after the end of treatment, during which time they attempted to conceive. Ten (31.25%) from all 32 treated women became pregnant. The highest incidence of pregnancy was in the stage I (12.5%) and II (12.5%) (rAFS) of endometriosis, a half of them in stage III (6.25%) and no pregnancy was recorded in the stage IV found prior to the beginning of therapy. There was no statistically significant (chi 2-test) relationship between the reduction of laparoscopic findings (defined as a visual extermination or as a decrease in staging of endometriosis) and pregnancy. In 19 (59.4%) from 32 treated women the stage of endometriosis remained unchanged, in 9 (28.3%) it was reduced by one up to three stages and in 4 (12.5%) the endometriosis was visually eliminated. In no case the staging of endometriosis was worsened during therapy. Gestrinone was well tolerated. In no one of patients it was necessary to interrupt the treatment untimely.
AuthorsJ Presl, J Laitl, L Pilka, P Ventruba
JournalCeskoslovenská gynekologie (Cesk Gynekol) Vol. 57 Issue 8 Pg. 401-7 (Oct 1992) ISSN: 0374-6852 [Print] CZECHOSLOVAKIA
Vernacular TitleGestrinon v terapii sterility pri endometrióze.
PMID1473163 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Gestrinone
  • Adult
  • Endometriosis (complications, pathology)
  • Female
  • Gestrinone (therapeutic use)
  • Humans
  • Infertility (drug therapy, etiology)
  • Pregnancy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: